Literature DB >> 24132822

Influence of preoperative chemotherapy on CT volumetric liver regeneration following right hemihepatectomy.

Simon A W G Dello1, Petra G Serbanescu Kele, Robert J Porte, Ronald M van Dam, Joost M Klaase, Cees Verhoef, Thomas van Gulik, Quintus Molenaar, Koop Bosscha, Eric J van der Jagt, Cornelis H C Dejong, Marieke T de Boer.   

Abstract

BACKGROUND: An increasing number of patients undergo major liver resection following preoperative chemotherapy. Liver regeneration may be impaired in these patients, predisposing them to postoperative liver dysfunction. The aim of the present study was to evaluate the effects of preoperative chemotherapy on liver regeneration after partial liver resection.
METHODS: Patients planned to receive right hepatectomy either with (group B) or without (group A) prior chemotherapy were identified retrospectively from a prospective multi-institutional database created in the conduct of a national randomized controlled trial (RCT). Prior chemotherapy was neither an inclusion nor an exclusion criterion of the trial. Future remnant liver volume (FRLV) was calculated by measuring total functional liver volume and resection specimen on preoperative computed tomography (CT) scans. Remnant liver volume after 7 days (V RLV7days) was measured on scheduled postoperative CT scans. The early regeneration index 7 days after surgery (RI early) was calculated as [(V RLV7days - FRLV) / FRLV] × 100 %. Data are expressed as median (interquartile range).
RESULTS: A total of 72 patients were enrolled: 45 in group A and 27 in group B. For the whole group, the liver remnant showed a 58 % (39 %) increase in volume at day 7 (1) day. The RI early was not significantly different between groups A and B, 60 % (36 %) and 50 % (43 %), respectively (p = 0.47). The RI early was significantly lower in patients who had undergone more than six cycles of chemotherapy.
CONCLUSIONS: Preoperative chemotherapy does not seem to have a negative impact on early liver regeneration after partial liver resection.

Entities:  

Mesh:

Year:  2014        PMID: 24132822     DOI: 10.1007/s00268-013-2278-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  29 in total

1.  Jejunectomy can reduce excessively elevated portal pressure after major hepatectomy in beagle dogs.

Authors:  Youichi Kawano; Koho Akimaru; Kaiyo Takubo; Koshi Matsumoto; Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Takashi Tajiri
Journal:  J Surg Res       Date:  2005-10-03       Impact factor: 2.192

2.  Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases.

Authors:  L Capussotti; A Muratore; M M Mulas; P Massucco; M Aglietta
Journal:  Br J Surg       Date:  2006-08       Impact factor: 6.939

3.  Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis.

Authors:  Takeshi Takamoto; Takuya Hashimoto; Keiji Sano; Yoshikazu Maruyama; Kazuto Inoue; Satoshi Ogata; Tamiko Takemura; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Ann Surg Oncol       Date:  2010-04-28       Impact factor: 5.344

4.  Randomized controlled trial analyzing the effect of 15 or 30 min intermittent Pringle maneuver on hepatocellular damage during liver surgery.

Authors:  Maartje A J van den Broek; Johanne G Bloemen; Simon A W G Dello; Marcel C G van de Poll; Steven W M Olde Damink; Cornelis H C Dejong
Journal:  J Hepatol       Date:  2010-12-13       Impact factor: 25.083

Review 5.  Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases.

Authors:  D Zorzi; A Laurent; T M Pawlik; G Y Lauwers; J-N Vauthey; E K Abdalla
Journal:  Br J Surg       Date:  2007-03       Impact factor: 6.939

6.  Early hepatic regeneration index and completeness of regeneration at 6 months after partial hepatectomy.

Authors:  P G Kele; M de Boer; E J van der Jagt; T Lisman; R J Porte
Journal:  Br J Surg       Date:  2012-06-14       Impact factor: 6.939

7.  Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.

Authors:  Hiroshi Nakano; Elie Oussoultzoglou; Edoardo Rosso; Selenia Casnedi; Marie-Pierre Chenard-Neu; Patrick Dufour; Philippe Bachellier; Daniel Jaeck
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

8.  Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab.

Authors:  Béatrice Aussilhou; Safi Dokmak; Sandrine Faivre; Valérie Paradis; Valérie Vilgrain; Jacques Belghiti
Journal:  Ann Surg Oncol       Date:  2009-04-11       Impact factor: 5.344

9.  Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.

Authors:  Jolien Tol; Miriam Koopman; Annemieke Cats; Cees J Rodenburg; Geert J M Creemers; Jolanda G Schrama; Frans L G Erdkamp; Allert H Vos; Cees J van Groeningen; Harm A M Sinnige; Dirk J Richel; Emile E Voest; Jeroen R Dijkstra; Marianne E Vink-Börger; Ninja F Antonini; Linda Mol; Johan H J M van Krieken; Otilia Dalesio; Cornelis J A Punt
Journal:  N Engl J Med       Date:  2009-02-05       Impact factor: 91.245

10.  Prospective volumetric assessment of the liver on a personal computer by nonradiologists prior to partial hepatectomy.

Authors:  Simon A W G Dello; Jan H M B Stoot; Rogier S A van Stiphout; Johanne G Bloemen; Stephen J Wigmore; Cornelis H C Dejong; Ronald M van Dam
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

View more
  5 in total

1.  Liver Regeneration is Preserved After At Least Four Repeated Liver Resections for Hepatocellular Carcinoma.

Authors:  Takamune Yamaguchi; Takashi Kokudo; Nobuhisa Akamatsu; Junichi Kaneko; Junichi Arita; Yoshihiro Sakamoto; Norihiro Kokudo; Kiyoshi Hasegawa
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

2.  Portal Vein Embolization Reduces Postoperative Hepatic Insufficiency Associated with Postchemotherapy Hepatic Atrophy.

Authors:  Kiyohiko Omichi; Suguru Yamashita; Jordan M Cloyd; Junichi Shindoh; Takashi Mizuno; Yun Shin Chun; Claudius Conrad; Thomas A Aloia; Jean-Nicolas Vauthey; Ching-Wei D Tzeng
Journal:  J Gastrointest Surg       Date:  2017-06-05       Impact factor: 3.452

3.  Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion : FLR Increase in Patients with CRLM Is Highest the First Week After PVO.

Authors:  Kristina Hasselgren; Per Sandström; Bård Ingvald Røsok; Ernesto Sparrelid; Gert Lindell; Peter Nørgaard Larsen; Anna Lindhoff Larsson; Nicolai A Schultz; Bjorn Atle Björnbeth; Bengt Isaksson; Magnus Rizell; Bergthor Björnsson
Journal:  J Gastrointest Surg       Date:  2018-11-21       Impact factor: 3.452

4.  The effect of preoperative chemotherapy on liver regeneration after portal vein embolization/ligation or liver resection in patients with colorectal liver metastasis: a systematic review protocol.

Authors:  Mihai-Calin Pavel; Raquel Casanova; Laia Estalella; Robert Memba; Erik Llàcer-Millán; Mar Achalandabaso; Elisabet Julià; Justin Geoghegan; Rosa Jorba
Journal:  Syst Rev       Date:  2020-12-04

5.  Factors Affecting Liver Regeneration in Living Donors After Hepatectomy.

Authors:  Cem Ibis; Yavor Asenov; Melih Akin; Ibrahim F Azamat; Nukhet Sivrikoz; Basak Gurtekin
Journal:  Med Sci Monit       Date:  2017-12-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.